|
|
|
|
|
My Recent Searches
|
|
|
|
|
|
|
|
Biomimetic Therapeutics, Inc. (BMTI) |
|
|
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14
|
|
Download |
|
|
Company
Roster
|
Total
Insiders : |
19 |
|
|
Total
Direct Shares :
|
876,611 |
|
Total
Indirect Shares :
|
4,725,404 |
|
%
Held by Insiders:
|
3.13% |
|
|
|
Filer's Name |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Christensen Thorkil K. |
Director |
2013-03-01 |
0 |
|
0 |
Watson Douglas G |
Director |
2013-03-01 |
0 |
|
0 |
Papasan Larry W |
Director |
2013-03-01 |
0 |
|
0 |
Burrill & Co (biotechnology Gp), Llc |
10% Owner |
2006-11-23 |
444,538 |
2006-05-11 |
0 |
Citron Mark Barry |
Former Officer |
2007-06-04 |
109,152 |
2007-06-04 |
0 |
Hart Charles Edward |
Chief Scientific Officer &VP |
2008-08-04 |
72,499 |
2008-03-31 |
0 |
Hirsch Steven Neal |
COO & Executive VP |
2010-03-23 |
182,491 |
2010-03-23 |
0 |
Douglas Earl Martin |
General Counsel |
2012-03-28 |
11,056 |
2008-01-23 |
0 |
Ehrlich Christopher B |
Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
Pagano Russell P. |
VP, Reg. & Clinical Affairs |
2013-03-01 |
0 |
2010-10-18 |
0 |
Friedlaender Gary E |
Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
Federico Charles |
Director |
2013-03-01 |
0 |
2008-03-28 |
0 |
Lynch Samuel Eugene |
President and CEO, Director |
2013-03-01 |
0 |
2013-03-01 |
0 |
Bullock Lawrence E |
Chief Financial Officer |
2013-03-01 |
0 |
2013-03-01 |
0 |
Murphy James G |
Director |
2013-03-01 |
0 |
2008-03-28 |
0 |
Novo A/s |
10% Owner |
2013-03-01 |
0 |
2006-05-11 |
0 |
Monsor James A. |
VP - Operations |
2008-03-05 |
56,875 |
2008-03-05 |
200 |
Hanham Ann |
Director, 10% Owner |
|
0 |
2006-05-11 |
2,353,433 |
Dyrberg Thomas |
Director, 10% Owner |
|
0 |
2007-01-25 |
2,371,771 |
|
|